Inhibition of retinal neovascularization by soluble EphA2 receptor
- 30 April 2006
- journal article
- Published by Elsevier BV in Experimental Eye Research
- Vol. 82 (4), 664-673
- https://doi.org/10.1016/j.exer.2005.09.004
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Impaired tumor microenvironment in EphA2‐deficient mice inhibits tumor angiogenesis and metastatic progressionThe FASEB Journal, 2005
- EphA2 receptor tyrosine kinase regulates endothelial cell migration and vascular assembly through phosphoinositide 3-kinase-mediated Rac1 GTPase activationJournal of Cell Science, 2004
- Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA ReceptorsNeoplasia, 2003
- Role for Extracellular Signal-Responsive Kinase-1 and -2 in Retinal AngiogenesisPublished by Association for Research in Vision and Ophthalmology (ARVO) ,2003
- Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivoOncogene, 2002
- Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesisGenes & Development, 1999
- VEGF localisation in diabetic retinopathyBritish Journal of Ophthalmology, 1998
- THE EPHRINS AND EPH RECEPTORS IN NEURAL DEVELOPMENTAnnual Review of Neuroscience, 1998
- Ephrins and their receptors: a repulsive topic?Cell and tissue research, 1997
- Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.Proceedings of the National Academy of Sciences of the United States of America, 1995